Hamed Samavat1, Allison M Dostal1, Renwei Wang2, Sarah Bedell1, Tim H Emory3, Giske Ursin4,5,6, Carolyn J Torkelson7, Myron D Gross8, Chap T Le9,10, Mimi C Yu6, Chung S Yang11, Douglas Yee10,12,13, Anna H Wu6, Jian-Min Yuan2,14, Mindy S Kurzer15. 1. Department of Food Science and Nutrition, University of Minnesota, St Paul, MN, USA. 2. Division of Cancer Control and Population Sciences, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. 3. Department of Radiology, Center for Magnetic Resonance Research, University of Minnesota Medical School, Minneapolis, MN, USA. 4. Cancer Registry of Norway, Oslo, Norway. 5. Department of Nutrition, University of Oslo, Oslo, Norway. 6. Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA. 7. Department of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis, MN, USA. 8. Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN, USA. 9. Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA. 10. Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. 11. Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA. 12. Department of Medicine, University of Minnesota, Minneapolis, MN, USA. 13. Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA. 14. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. 15. Department of Food Science and Nutrition, University of Minnesota, St Paul, MN, USA. mkurzer@umn.edu.
Abstract
PURPOSE: The Minnesota Green Tea Trial (MGTT) was a randomized, placebo-controlled, double-blinded trial investigating the effect of daily green tea extract consumption for 12 months on biomarkers of breast cancer risk. METHODS:Participants were healthy postmenopausal women at high risk of breast cancer due to dense breast tissue with differing catechol-O-methyltransferase (COMT) genotypes. The intervention was a green tea catechin extract containing 843.0 ± 44.0 mg/day epigallocatechin gallate or placebo capsules for 1 year. Annual digital screening mammograms were obtained at baseline and month 12, and fasting blood and 24-h urine samples were provided at baseline and at months 6 and 12. Primary endpoints included changes in percent mammographic density, circulating endogenous sex hormones, and insulin-like growth factor axis proteins; secondary endpoints were changes in urinary estrogens and estrogen metabolites and circulating F2-isoprostanes, a biomarker of oxidative stress. RESULTS: The MGTT screened more than 100,000 mammograms and randomized 1,075 participants based on treatment (green tea extract vs. placebo), stratified by COMT genotype activity (high COMT vs. low/intermediate COMT genotype activity). A total of 937 women successfully completed the study and 138 dropped out (overall dropout rate = 12.8 %). CONCLUSIONS: In this paper we report the rationale, design, recruitment, participant characteristics, and methods for biomarker and statistical analyses.
RCT Entities:
PURPOSE: The Minnesota Green Tea Trial (MGTT) was a randomized, placebo-controlled, double-blinded trial investigating the effect of daily green tea extract consumption for 12 months on biomarkers of breast cancer risk. METHODS:Participants were healthy postmenopausal women at high risk of breast cancer due to dense breast tissue with differing catechol-O-methyltransferase (COMT) genotypes. The intervention was a green tea catechin extract containing 843.0 ± 44.0 mg/day epigallocatechin gallate or placebo capsules for 1 year. Annual digital screening mammograms were obtained at baseline and month 12, and fasting blood and 24-h urine samples were provided at baseline and at months 6 and 12. Primary endpoints included changes in percent mammographic density, circulating endogenous sex hormones, and insulin-like growth factor axis proteins; secondary endpoints were changes in urinary estrogens and estrogen metabolites and circulating F2-isoprostanes, a biomarker of oxidative stress. RESULTS: The MGTT screened more than 100,000 mammograms and randomized 1,075 participants based on treatment (green tea extract vs. placebo), stratified by COMT genotype activity (high COMT vs. low/intermediate COMT genotype activity). A total of 937 women successfully completed the study and 138 dropped out (overall dropout rate = 12.8 %). CONCLUSIONS: In this paper we report the rationale, design, recruitment, participant characteristics, and methods for biomarker and statistical analyses.
Entities:
Keywords:
Breast cancer; Green tea; Mammographic density; Postmenopausal women; Sex hormones
Authors: H H Chow; Y Cai; D S Alberts; I Hakim; R Dorr; F Shahi; J A Crowell; C S Yang; Y Hara Journal: Cancer Epidemiol Biomarkers Prev Date: 2001-01 Impact factor: 4.254
Authors: Ming Li; Zhiwei He; Svetlana Ermakova; Duo Zheng; Faqing Tang; Yong-Yeon Cho; Feng Zhu; Wei-Ya Ma; Yuk Sham; Evgeny A Rogozin; Ann M Bode; Ya Cao; Zigang Dong Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-03 Impact factor: 4.254
Authors: Myron Gross; Michael Steffes; David R Jacobs; Xinhua Yu; Linda Lewis; Cora E Lewis; Catherine M Loria Journal: Clin Chem Date: 2004-10-28 Impact factor: 8.327
Authors: J R Hilditch; J Lewis; A Peter; B van Maris; A Ross; E Franssen; G H Guyatt; P G Norton; E Dunn Journal: Maturitas Date: 1996-07 Impact factor: 4.342
Authors: V Neveu; J Perez-Jiménez; F Vos; V Crespy; L du Chaffaut; L Mennen; C Knox; R Eisner; J Cruz; D Wishart; A Scalbert Journal: Database (Oxford) Date: 2010-01-08 Impact factor: 3.451
Authors: Wael A Salameh; Mildred M Redor-Goldman; Nigel J Clarke; Richard E Reitz; Michael P Caulfield Journal: Steroids Date: 2009-11-17 Impact factor: 2.668
Authors: Z Y Wang; M T Huang; Y R Lou; J G Xie; K R Reuhl; H L Newmark; C T Ho; C S Yang; A H Conney Journal: Cancer Res Date: 1994-07-01 Impact factor: 12.701
Authors: Hamed Samavat; April R Newman; Renwei Wang; Jian-Min Yuan; Anna H Wu; Mindy S Kurzer Journal: Am J Clin Nutr Date: 2016-11-02 Impact factor: 7.045
Authors: Hamed Samavat; Giske Ursin; Tim H Emory; Eunjung Lee; Renwei Wang; Carolyn J Torkelson; Allison M Dostal; Karen Swenson; Chap T Le; Chung S Yang; Mimi C Yu; Douglas Yee; Anna H Wu; Jian-Min Yuan; Mindy S Kurzer Journal: Cancer Prev Res (Phila) Date: 2017-09-13
Authors: Allison M Dostal; Hamed Samavat; Luis Espejo; Andrea Y Arikawa; Nicole R Stendell-Hollis; Mindy S Kurzer Journal: J Nutr Date: 2015-11-18 Impact factor: 4.798
Authors: Zheming Yu; Hamed Samavat; Allison M Dostal; Renwei Wang; Carolyn J Torkelson; Chung S Yang; Lesley M Butler; Thomas W Kensler; Anna H Wu; Mindy S Kurzer; Jian-Min Yuan Journal: Cancer Prev Res (Phila) Date: 2017-08-01